EFMC-ISMC 2018 XXV - EFMC International Symposium on Medicinal Chemistry

1/ Abstract

> Nanocyclix: Next Generation Kinase Therapeutics - A Chemocentric approach For The Discovery Of Selective Kinase Inhibitors
 Oncodesign SA (France)


By closing this message, you consent to our cookies on this device in accordance with our cookie policy unless you have disabled them.